233 related articles for article (PubMed ID: 28402987)
1. New insights into redox homeostasis as a therapeutic target in B-cell malignancies.
Graczyk-Jarzynka A; Zagozdzon R; Muchowicz A; Siernicka M; Juszczynski P; Firczuk M
Curr Opin Hematol; 2017 Jul; 24(4):393-401. PubMed ID: 28402987
[TBL] [Abstract][Full Text] [Related]
2. cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies.
Domka K; Goral A; Firczuk M
Front Immunol; 2020; 11():1538. PubMed ID: 32793211
[TBL] [Abstract][Full Text] [Related]
3. Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma.
Waibel M; Gregory G; Shortt J; Johnstone RW
Curr Opin Hematol; 2014 Jul; 21(4):297-308. PubMed ID: 24811162
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.
Huang J; Fairbrother W; Reed JC
Expert Rev Hematol; 2015 Jun; 8(3):283-97. PubMed ID: 25912824
[TBL] [Abstract][Full Text] [Related]
6. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
Puri KD; Di Paolo JA; Gold MR
Int Rev Immunol; 2013 Aug; 32(4):397-427. PubMed ID: 23886342
[TBL] [Abstract][Full Text] [Related]
7. Experimental therapeutics: targeting the redox Achilles heel of cancer.
Cabello CM; Bair WB; Wondrak GT
Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
[TBL] [Abstract][Full Text] [Related]
8. Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.
Buchner M; Müschen M
Curr Opin Hematol; 2014 Jul; 21(4):341-9. PubMed ID: 24811161
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.
Maxwell SA; Mousavi-Fard S
Exp Biol Med (Maywood); 2013 Sep; 238(9):971-90. PubMed ID: 23986223
[TBL] [Abstract][Full Text] [Related]
10. Selective induction of oxidative stress in cancer cells via synergistic combinations of agents targeting redox homeostasis.
Akladios FN; Andrew SD; Parkinson CJ
Bioorg Med Chem; 2015 Jul; 23(13):3097-104. PubMed ID: 26022081
[TBL] [Abstract][Full Text] [Related]
11. B-cell receptor signaling in chronic lymphocytic leukemia and other B-cell malignancies.
Koehrer S; Burger JA
Clin Adv Hematol Oncol; 2016 Jan; 14(1):55-65. PubMed ID: 27057669
[TBL] [Abstract][Full Text] [Related]
12. Targeting Redox Metabolism in Pancreatic Cancer.
Abdel Hadi N; Reyes-Castellanos G; Carrier A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546421
[TBL] [Abstract][Full Text] [Related]
13. Understanding of ROS-Inducing Strategy in Anticancer Therapy.
Kim SJ; Kim HS; Seo YR
Oxid Med Cell Longev; 2019; 2019():5381692. PubMed ID: 31929855
[TBL] [Abstract][Full Text] [Related]
14. On the redox control of B lymphocyte differentiation and function.
Bertolotti M; Sitia R; Rubartelli A
Antioxid Redox Signal; 2012 May; 16(10):1139-49. PubMed ID: 22229488
[TBL] [Abstract][Full Text] [Related]
15. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
Dominguez PM; Teater M; Shaknovich R
Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
[TBL] [Abstract][Full Text] [Related]
16. Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.
Trzeciecka A; Klossowski S; Bajor M; Zagozdzon R; Gaj P; Muchowicz A; Malinowska A; Czerwoniec A; Barankiewicz J; Domagala A; Chlebowska J; Prochorec-Sobieszek M; Winiarska M; Ostaszewski R; Gwizdalska I; Golab J; Nowis D; Firczuk M
Oncotarget; 2016 Jan; 7(2):1717-31. PubMed ID: 26636537
[TBL] [Abstract][Full Text] [Related]
17. Curcumin mediates time and concentration dependent regulation of redox homeostasis leading to cytotoxicity in macrophage cells.
Kunwar A; Sandur SK; Krishna M; Priyadarsini KI
Eur J Pharmacol; 2009 Jun; 611(1-3):8-16. PubMed ID: 19344704
[TBL] [Abstract][Full Text] [Related]
18. Spatio-temporal changes in glutathione and thioredoxin redox couples during ionizing radiation-induced oxidative stress regulate tumor radio-resistance.
Patwardhan RS; Sharma D; Checker R; Thoh M; Sandur SK
Free Radic Res; 2015 Oct; 49(10):1218-32. PubMed ID: 26021764
[TBL] [Abstract][Full Text] [Related]
19. L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?
Haddad JJ; Harb HL
Mol Immunol; 2005 May; 42(9):987-1014. PubMed ID: 15829290
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic Acid Coordinating with Sodium Selenite Promotes Paraptosis in Colorectal Cancer Cells by Disrupting the Redox Homeostasis and Activating the MAPK Pathway.
Zhao S; Meng Y; Cai W; Luo Q; Gao H; Shen Q; Shi D
Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]